Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma
Clinical trial NCT00600002 · COMPLETED
Trial details
- NCT number
- NCT00600002
- Sponsor
- Edward Nelson
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2018-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.